Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2014

01-01-2014 | Original Research

Sustainability of Quality Improvement Following Removal of Pay-for-Performance Incentives

Authors: Justin K. Benzer, PhD, Gary J. Young, PhD, James F. Burgess Jr, PhD, Errol Baker, PhD, David C. Mohr, PhD, Martin P. Charns, DBA, Peter J. Kaboli, MD, MS

Published in: Journal of General Internal Medicine | Issue 1/2014

Login to get access

ABSTRACT

BACKGROUND

Although pay-for-performance (P4P) has become a central strategy for improving quality in US healthcare, questions persist about the effectiveness of these programs. A key question is whether quality improvement that occurs as a result of P4P programs is sustainable, particularly if incentives are removed.

OBJECTIVE

To investigate sustainability of performance levels following removal of performance-based incentives.

DESIGN, SETTING, AND PARTICIPANTS

Observational cohort study that capitalized on a P4P program within the Veterans Health Administration (VA) that included adoption and subsequent removal of performance-based incentives for selected inpatient quality measures. The study sample comprised 128 acute care VA hospitals where performance was assessed between 2004 and 2010.

INTERVENTION

VA system managers set annual performance goals in consultation with clinical leaders, and report performance scores to medical centers on a quarterly basis. These scores inform performance-based incentives for facilities and their managers. Bonuses are distributed based on the attainment of these performance goals.

MEASUREMENTS

Seven quality of care measures for acute coronary syndrome, heart failure, and pneumonia linked to performance-based incentives.

RESULTS

Significant improvements in performance were observed for six of seven quality of care measures following adoption of performance-based incentives and were maintained up to the removal of the incentive; subsequently, the observed performance levels were sustained.

LIMITATIONS

This is a quasi-experimental study without a comparison group; causal conclusions are limited.

CONCLUSION

The maintenance of performance levels after removal of a performance-based incentive has implications for the implementation of Medicare’s value-based purchasing initiative and other P4P programs. Additional research is needed to better understand human and system-level factors that mediate sustainability of performance-based incentives.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788–1793.PubMedCrossRef Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788–1793.PubMedCrossRef
2.
go back to reference Millett C, Gray J, Saxena S, Netuveli G, Majeed A. Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ. 2007;176(12):1705–1710.PubMedCentralPubMedCrossRef Millett C, Gray J, Saxena S, Netuveli G, Majeed A. Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ. 2007;176(12):1705–1710.PubMedCentralPubMedCrossRef
3.
go back to reference Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375–384.PubMedCrossRef Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375–384.PubMedCrossRef
4.
go back to reference Chung S, Palaniappan LP, Trujillo LM, Rubin HR, Luft HS. Effect of physician-specific pay-for-performance incentives in a large group practice. Am J Manag Care. 2010;16(2):e35–e42.PubMed Chung S, Palaniappan LP, Trujillo LM, Rubin HR, Luft HS. Effect of physician-specific pay-for-performance incentives in a large group practice. Am J Manag Care. 2010;16(2):e35–e42.PubMed
5.
go back to reference Christianson JB, Leatherman S, Sutherland K. Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence. Med Care Res Rev. 2008;65(6 Suppl):5S–35S.PubMedCrossRef Christianson JB, Leatherman S, Sutherland K. Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence. Med Care Res Rev. 2008;65(6 Suppl):5S–35S.PubMedCrossRef
6.
go back to reference Glasgow JM, Scott-Caziewell JR, Kaboli PJ. Guiding inpatient quality improvement: a systematic review of lean and six sigma. Joint Comm J Qual Patient Saf. 2010;36(12):533–540. Glasgow JM, Scott-Caziewell JR, Kaboli PJ. Guiding inpatient quality improvement: a systematic review of lean and six sigma. Joint Comm J Qual Patient Saf. 2010;36(12):533–540.
8.
go back to reference Hysong SJ, Khan MM, Petersen LA. Passive monitoring versus active assessment of clinical performance: impact on measured quality of care. Med Care. 2011;49(10):883–890.PubMedCrossRef Hysong SJ, Khan MM, Petersen LA. Passive monitoring versus active assessment of clinical performance: impact on measured quality of care. Med Care. 2011;49(10):883–890.PubMedCrossRef
9.
go back to reference Glasgow JM, Davies ML, Kaboli PJ. Findings from a national improvement collaborative: are improvements sustained? BMJ Qual Saf. 2012;21(8):663–669.PubMedCrossRef Glasgow JM, Davies ML, Kaboli PJ. Findings from a national improvement collaborative: are improvements sustained? BMJ Qual Saf. 2012;21(8):663–669.PubMedCrossRef
10.
go back to reference Lester H, Schmittdiel J, Selby J, Fireman B, Campbell S, Lee J, et al. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ. 2010;340:c1898.PubMedCentralPubMedCrossRef Lester H, Schmittdiel J, Selby J, Fireman B, Campbell S, Lee J, et al. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ. 2010;340:c1898.PubMedCentralPubMedCrossRef
11.
go back to reference Kizer KW, Dudley RA. Extreme makeover: transformation of the veterans health care system. Annu Rev Public Health. 2009;30:313–339.PubMedCrossRef Kizer KW, Dudley RA. Extreme makeover: transformation of the veterans health care system. Annu Rev Public Health. 2009;30:313–339.PubMedCrossRef
12.
go back to reference Hannan EL, Kilburn H Jr, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271(10):761–766.PubMedCrossRef Hannan EL, Kilburn H Jr, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271(10):761–766.PubMedCrossRef
13.
go back to reference Werner RM, Bradlow ET. Public reporting on hospital process improvements is linked to better patient outcomes. Health Aff (Millwood). 2010;29(7):1319–1324.CrossRef Werner RM, Bradlow ET. Public reporting on hospital process improvements is linked to better patient outcomes. Health Aff (Millwood). 2010;29(7):1319–1324.CrossRef
14.
go back to reference Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health Aff (Millwood). 2005;24(4):1150–1160.CrossRef Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health Aff (Millwood). 2005;24(4):1150–1160.CrossRef
15.
go back to reference Smith MA, Wright A, Queram C, Lamb GC. Public reporting helped drive quality improvement in outpatient diabetes care among Wisconsin physician groups. Health Aff (Millwood). 2012;31(3):570–577.CrossRef Smith MA, Wright A, Queram C, Lamb GC. Public reporting helped drive quality improvement in outpatient diabetes care among Wisconsin physician groups. Health Aff (Millwood). 2012;31(3):570–577.CrossRef
16.
go back to reference Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356(5):486–496.PubMedCrossRef Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356(5):486–496.PubMedCrossRef
17.
go back to reference Bokhour BG, Burgess JF Jr, Hook JM, White B, Berlowitz D, Guldin MR, et al. Incentive implementation in physician practices: a qualitative study of practice executive perspectives on pay for performance. Med Care Res Rev. 2006;63(1 Suppl):73S–95S.PubMedCrossRef Bokhour BG, Burgess JF Jr, Hook JM, White B, Berlowitz D, Guldin MR, et al. Incentive implementation in physician practices: a qualitative study of practice executive perspectives on pay for performance. Med Care Res Rev. 2006;63(1 Suppl):73S–95S.PubMedCrossRef
Metadata
Title
Sustainability of Quality Improvement Following Removal of Pay-for-Performance Incentives
Authors
Justin K. Benzer, PhD
Gary J. Young, PhD
James F. Burgess Jr, PhD
Errol Baker, PhD
David C. Mohr, PhD
Martin P. Charns, DBA
Peter J. Kaboli, MD, MS
Publication date
01-01-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2572-4

Other articles of this Issue 1/2014

Journal of General Internal Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.